Skip to main content

Table 2 Distributions of tumor size and tumor grade in Recurrence Score categories for all 220 cases and 570 controls

From: A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

Variable (number of patients)

Recurrence Score

 
 

< 18

(n = 379)

18–30

(n = 162)

≥30

(n = 249)

Correlation1

(P value)

Tumor size (cm)

      

0.25 (<0.0001)

   ≤1 (n = 242)

147

(61%)

51

(21%)

44

(18%)

 

   1.1–2 (n = 348)

173

(50%)

65

(19%)

110

(32%)

 

   2.1–4 (n = 186)

55

(30%)

44

(24%)

87

(47%)

 

   >4 (n = 14)

4

(29%)

2

(14%)

8

(57%)

 

Tumor grade pathologist 1

      

0.54 (<0.0001)

   Well (n = 200)

146

(73%)

44

(22%)

10

(5%)

 

   Moderate (n = 353)

199

(56%)

90

(25%)

64

(18%)

 

   Poor (n = 237)

34

(14%)

28

(12%)

175

(74%)

 

Tumor size and grade

      

0.42 (<0.0001)

   ≤2 cm and well or ≤1 cm and moderate (n = 285)

204

(72%)

60

(21%)

21

(7%)

 

   >2 cm and well, or 1.1–2 cm and moderate, or ≤2 cm and poor (n = 330)

143

(41%)

63

(19%)

133

(40%)

 

   >2 cm and moderate/poor (n = 175)

41

(23%)

39

(22%)

95

(54%)

 
  1. 1Spearman rank correlation